ORAGENICS INC Contracts & Agreements

Second Amendment to 2021 Equity Incentive Plan (Filed With SEC on December 16, 2024)

Sales Agreement dated, October 11, 2024, between Oragenics, Inc. and Dawson James Securities, Inc (Filed With SEC on October 15, 2024)

Placement Agency Agreement dated, September 4, 2024, between Oragenics, Inc. and Dawson James Securities, Inc (Filed With SEC on September 5, 2024)

Form of Pre-Funded Warrant (Filed With SEC on September 5, 2024)

Form of Placement Agent Warrant (Filed With SEC on September 5, 2024)

Warrant Agency Agreement (Filed With SEC on September 5, 2024)

Form of Securities Purchase Agreement (Filed With SEC on September 5, 2024)

At-The-Market Issuance Sales Agreement between the Company and Ascendiant Capital Markets, LLC dated August 8, 2024 (Filed With SEC on August 9, 2024)

Placement Agency Agreement dated June 25, 2024 between Oragenics, Inc. and Dawson James Securities, Inc (Filed With SEC on June 26, 2024)

Form of Placement Agent Warrant (Filed With SEC on June 26, 2024)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 29, 2024)

Underwriting Agreement dated February 27, 2024 between Oragenics, Inc. and ThinkEquity LLC (Filed With SEC on March 1, 2024)

Form of Representatives Warrants (Filed With SEC on March 1, 2024)

Description of Securities (Filed With SEC on March 1, 2024)

Executive Employment Agreement for Mr. Redmond dated December 28, 2023 (Filed With SEC on December 29, 2023)

2021 Equity Incentive Plan (Filed With SEC on December 15, 2023)

First Amendment to 2021 Equity Incentive Plan (Filed With SEC on December 15, 2023)

Asset Purchase Agreement (Filed With SEC on October 5, 2023)

Three-Way Collaborative Research Agreement (Filed With SEC on August 11, 2023)

Form of Restricted Stock Award Agreement (Filed With SEC on August 10, 2023)

Form of Securities Purchase Agreement (Filed With SEC on August 7, 2023)

Inspirevax License Agreement (Filed With SEC on May 12, 2023)

NRC Technology License Amendment 5 (Filed With SEC on May 12, 2023)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 17, 2023)

Executive Employment Agreement for Ms. Huffman dated effective March 7, 2023 (Filed With SEC on March 8, 2023)

At the Market Offering Agreement dated February 24, 2023, by and among Oragenics, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on February 24, 2023)

Specimen Stock Certificate (Filed With SEC on January 23, 2023)

NRC Technology License Amendment 4 (Filed With SEC on August 9, 2022)

Executive Employment Agreement for Ms. Murphy dated June 23, 2022 (Filed With SEC on June 23, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 24, 2022)

NRC Technology License Amendment 2 (Filed With SEC on March 24, 2022)

NRC Technology License Amendment 3 (Filed With SEC on March 24, 2022)

2021 Equity Incentive Plan (Filed With SEC on February 28, 2022)

Form Stock Option Award Agreement (Directors) (Filed With SEC on February 28, 2022)

Form Stock Option Award Agreement (Employees) (Filed With SEC on February 28, 2022)

Form Stock Option Award Agreement (Consultants) (Filed With SEC on February 28, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act Of 1934 (Filed With SEC on March 1, 2021)

Amended and Restated Exclusive Channel Collaboration Agreement by and between Oragenics, Inc. and Eleszto Genetika, Inc. dated as of March 1, 2021(Lantibiotic ECC) (Filed With SEC on March 1, 2021)

Sales Agent Agreement dated February 1, 2021 (Filed With SEC on February 1, 2021)

Placement Agent Agreement dated December 23, 2020 (Filed With SEC on December 28, 2020)

Form of Securities Purchase Agreement (Filed With SEC on December 28, 2020)

Underwriting Agreement dated November 19, 2020 (Filed With SEC on November 24, 2020)

Non-exclusive intellectual property and biological materials license agreement with the National Institute of Allergy and Infectious Diseases, an institute within the National... (Filed With SEC on August 14, 2020)

Second Amendment to Employment Agreement between the Company and Alan Joslyn effective June 6, 2020 (Filed With SEC on June 5, 2020)

Warrant, dated May 1, 2020 (Filed With SEC on May 4, 2020)

Stock Purchase Agreement, dated May 1, 2020 (Filed With SEC on May 4, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act Of 1934 (Filed With SEC on March 4, 2020)

Notice of Assignment of Lantibiotic ECC and Lantibiotic SIA by and between Oragenics, Inc. and Intrexon Corporation (n/k/a Precigen Inc.) to ILH Holdings Inc. effective January 1,... (Filed With SEC on March 4, 2020)

Second Amendment to Lease Agreement between the Company and Hawley-Wiggins LLC dated July 13, 2014 (13700 Progress Blvd, Alachua, FL 32615) (Filed With SEC on March 4, 2020)

Form of Notice of Grant of Stock Options and Stock Option Award Agreement (Directors) (Filed With SEC on March 4, 2020)

Fourth Amendment to 2012 Equity Incentive Plan (Filed With SEC on June 21, 2019)

Specimen Stock Certificate (Filed With SEC on March 29, 2019)

Underwriting Agreement dated March 21, 2019 (Filed With SEC on March 25, 2019)

Form of Series 1 Warrant (Filed With SEC on March 25, 2019)

Form of Series 2 Warrant (Filed With SEC on March 25, 2019)

Exclusive Channel Collaboration Agreement with Intrexon Corporation dated June 9, 2015, as amended and subsequently assigned to ActoBio Therapeutics, Inc., a wholly owned... (Filed With SEC on August 13, 2018)

Underwriting Agreement dated as of July 13, 2017 by and between Oragenics, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on July 17, 2018)

Form of Warrant (Filed With SEC on July 17, 2018)

Warrant Agency Agreement (Filed With SEC on July 17, 2018)

Form of Warrant to purchase shares of Common Stock (Filed With SEC on July 11, 2018)

Form of Underwriting Agreement (Filed With SEC on July 9, 2018)

Form of Certificate of Designation of Series D Preferred Stock (Filed With SEC on July 9, 2018)

Form of Warrant to purchase shares of Common Stock (Filed With SEC on July 9, 2018)

Third Amendment to 2012 Equity Incentive Plan (Filed With SEC on June 26, 2018)

First Amendment to Employment Agreement between the Company and Alan Joslyn effective June 6, 2018 (Filed With SEC on June 11, 2018)

Placement Agency Agreement dated as of April 6, 2018 (Filed With SEC on April 10, 2018)

Form of Investor Warrant (Filed With SEC on April 10, 2018)

Form of Securities Purchase Agreement, dated as of April 6, 2018, by and among Oragenics, Inc. and the Investors (Filed With SEC on April 10, 2018)

Notice of Assignment of Exclusive Channel Collaboration Agreement between Oragenics, Inc. and Intrexon Corporation, effective January 1, 2018 (Filed With SEC on February 16, 2018)

Notice of Assignment to Oral Mucositis SIA by and between Oragenics, Inc. and Intrexon Corporation between Oragenics, Inc. and Intrexon Corporation, effective January 1, 2018 (Filed With SEC on February 16, 2018)

Joinder to Assignment of Oral Mucositis SIA by and between Oragenics, Inc. and Intrexon Corporation between Oragenics, Inc. and Intrexon Corporation, effective January 1, 2018 (Filed With SEC on February 16, 2018)

Second Amendment to 2012 Equity Incentive Plan (Filed With SEC on December 29, 2017)

Form of Common Stock Purchase Warrant (Filed With SEC on November 9, 2017)

Securities Purchase Agreement dated November 8, 2017 (Filed With SEC on November 9, 2017)

Registration Rights Agreement dated November 8, 2017 (Filed With SEC on November 9, 2017)

Debt Conversion Agreement-Intrexon dated November 8, 2017 (Filed With SEC on November 9, 2017)

Amendment No. 2 to the Exclusive Channel Collaboration Agreement between Oragenics, Inc. and Intrexon Corporation dated November 8, 2017 (Filed With SEC on November 9, 2017)

Amendment to Stock Issuance Agreement between Oragenics, Inc. and Intrexon Corporation dated November 8, 2017 (Filed With SEC on November 9, 2017)

Amendment No. 2 to the Exclusive Channel Collaboration Agreement between Oragenics, Inc. and Intrexon Corporation dated November 8, 2017 (Filed With SEC on November 9, 2017)

Second Amendment to Stock Issuance Agreement between Oragenics, Inc. and Intrexon Corporation dated November 8, 2017 (Filed With SEC on November 9, 2017)

Form of Amended and Restated Common Stock Purchase Warrant (Filed With SEC on August 1, 2017)

AGREEMENT TO AMEND COMMON STOCK WARRANTS (Filed With SEC on August 1, 2017)

ORAGENICS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on May 11, 2017)

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ACT), OR ANY APPLICABLE STATESECURITIES LAWS. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED... (Filed With SEC on May 11, 2017)

ORAGENICS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 11, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 11, 2017)

NOTE PURCHASE AGREEMENT (Filed With SEC on May 11, 2017)

AMENDMENT TO EXCLUSIVE CHANNEL COLLABORATIONAGREEMENT (Filed With SEC on May 11, 2017)

AMENDMENT TO STOCK ISSUANCE AGREEMENT (Filed With SEC on May 11, 2017)

FIRST AMENDMENT TO AMENDED AND RESTATED ORAGENICS, INC. 2012EQUITY INCENTIVE PLAN (Filed With SEC on May 5, 2017)

AMENDMENT NO. 1 TO UNSECURED PROMISSORY NOTE (Filed With SEC on September 15, 2016)

FIRST AMENDMENT TO EXCLUSIVE CHANNEL COLLABORATION AGREEMENT (Filed With SEC on August 15, 2016)

ORAGENICS, INC. STOCKPURCHASE AGREEMENT (Filed With SEC on June 30, 2016)

UNSECURED PROMISSORY NOTE (Filed With SEC on June 30, 2016)

PROMISSORY NOTE (Filed With SEC on June 27, 2016)

GUARANTY (Filed With SEC on June 27, 2016)

TRANSITIONSERVICES AGREEMENT (Filed With SEC on June 27, 2016)

SUBLEASEAGREEMENT (Filed With SEC on June 27, 2016)

ASSET PURCHASEAGREEMENT By and Among PROBIORA HEALTH, LLC, a Delawarelimited liability company (Buyer), CHRISTINE L. KOSKI, The SoleMember and Manager of Buyer and a Personal... (Filed With SEC on June 23, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on June 6, 2016)

AMENDMENT NO. 1 TO THE LICENSEAGREEMENT between Oragenics,Inc. and The Texas A&MUniversity System (Filed With SEC on August 7, 2015)

SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on August 7, 2015)

EXCLUSIVE CHANNEL COLLABORATION AGREEMENT (Filed With SEC on June 11, 2015)

STOCK ISSUANCE AGREEMENT (Filed With SEC on June 11, 2015)

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ACT), OR ANY APPLICABLE STATESECURITIES LAWS. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED... (Filed With SEC on June 11, 2015)

Oragenics, Inc. Notice of Grant of Stock Options and Stock Option Award Agreement (Filed With SEC on March 18, 2015)

FORM OF RESTRICTED STOCK AGREEMENT (Filed With SEC on March 18, 2015)

AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 25, 2015)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 25, 2015)

FIRST AMENDMENT TO LEASE (Filed With SEC on August 7, 2014)

4,400,000 Shares ORAGENICS, INC. CommonStock UNDERWRITING AGREEMENT (Filed With SEC on November 15, 2013)

EXCLUSIVE CHANNEL COLLABORATION AGREEMENT (Filed With SEC on October 1, 2013)

STOCK PURCHASE AND ISSUANCE AGREEMENT (Filed With SEC on October 1, 2013)

FIRST AMENDMENT TO THE STOCK PURCHASE AND ISSUANCE AGREEMENT (Filed With SEC on October 1, 2013)

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ACT), OR ANY APPLICABLE STATESECURITIES LAWS. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED... (Filed With SEC on October 1, 2013)

FIFTH AMENDMENT TO LICENSE AGREEMENT UFRF REFERENCE NUMBER A1502 (Filed With SEC on April 23, 2013)

FIFTH AMENDMENT TO LICENSE AGREEMENT UFRF REFERENCE NUMBER A0376 (Filed With SEC on April 23, 2013)

Oragenics, Inc. Notice of Grant of Stock Options and Stock Option Award Agreement (Filed With SEC on March 26, 2013)

[Form of LTIP Employee Award Agreement Amendment] [Date] (Filed With SEC on February 15, 2013)

[Form of LTIP Non-Employee Award Agreement Amendment] [Date] (Filed With SEC on February 15, 2013)

AMENDED AND RESTATED ORAGENICS, INC. 2012 EQUITY INCENTIVE PLAN SECTION 1 BACKGROUND AND PURPOSE (Filed With SEC on October 25, 2012)

ORAGENICS, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on August 2, 2012)

ORAGENICS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 2, 2012)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORAGENICS, INC. Expires , 2017 (Filed With SEC on August 2, 2012)

EXCLUSIVE CHANNEL COLLABORATIONAGREEMENT (Filed With SEC on June 11, 2012)

STOCK ISSUANCE AGREEMENT (Filed With SEC on June 11, 2012)

FIRST AMENDMENT TO SECURITY AGREEMENT (Filed With SEC on June 11, 2012)

SENIOR SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on May 15, 2012)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORAGENICS, INC. (Filed With SEC on May 15, 2012)

LEASE (Filed With SEC on April 16, 2012)

LICENSE AGREEMENT Between Oragenics Inc and The Texas A& M University System (Filed With SEC on April 16, 2012)

EXCHANGE OF NOTES FOR EQUITY AGREEMENT (Filed With SEC on March 26, 2012)

LOAN AGREEMENT (Filed With SEC on March 26, 2012)

SECURITY AGREEMENT (Filed With SEC on March 26, 2012)

SENIOR SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 26, 2012)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORAGENICS, INC. (Filed With SEC on March 26, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 2, 2012)

FIFTH AMENDMENT TO REVOLVING CREDIT AGREEMENT Between: THEKOSKI FAMILY LIMITED PARTNERSHIP, a Texas Limited Partnership as Lender and ORAGENICS, Inc., a Florida Corporation as... (Filed With SEC on January 25, 2012)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on January 25, 2012)

FOURTH AMENDMENT TO REVOLVING CREDIT AGREEMENT Between: THEKOSKI FAMILY LIMITED PARTNERSHIP, a Texas Limited Partnership as Lender and ORAGENICS, Inc., a Florida Corporation as... (Filed With SEC on December 14, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on December 14, 2011)

[Form of LTIP Employee Award Agreement] (Filed With SEC on November 17, 2011)

[Form of LTIP Director Award Agreement] (Filed With SEC on November 17, 2011)

FOURTH AMENDMENT TO ORAGENICS, INC. AMENDED AND RESTATED 2002 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on November 14, 2011)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on October 6, 2011)

THIRD AMENDMENT TO AMENDED AND RESTATED ORAGENICS, INC. 2002 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on September 1, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on August 5, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on July 12, 2011)

THIRD AMENDMENT TO REVOLVING CREDIT AGREEMENT Between: THEKOSKI FAMILY LIMITED PARTNERSHIP, a Texas Limited Partnership as Lender and ORAGENICS, Inc., a Florida Corporation as... (Filed With SEC on June 30, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on June 7, 2011)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 26, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on May 10, 2011)

TOTAL PRICE OF PREMIUMS (Filed With SEC on May 10, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on April 11, 2011)

[March 15, 2011 Promissory Note] (Filed With SEC on March 15, 2011)

SECOND AMENDMENT TO REVOLVING CREDIT AGREEMENT Between: THEKOSKI FAMILY LIMITED PARTNERSHIP, a Texas Limited Partnership as Lender and ORAGENICS, Inc., a Florida Corporation as... (Filed With SEC on February 8, 2011)

FIRST AMENDMENT TO REVOLVING CREDIT AGREEMENT Between: THEKOSKI FAMILY LIMITED PARTNERSHIP, a Texas Limited Partnership as Lender and ORAGENICS, Inc., a Florida Corporation as... (Filed With SEC on January 28, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on January 28, 2011)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on November 12, 2010)

ORAGENICS, INC. __________Shares1 Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on October 5, 2010)

Additional abbreviations may also be used though not in the above list. FOR VALUE RECEIVED, the undersigned hereby sells, assigns andtransfers unto (Filed With SEC on October 5, 2010)

REVOLVING UNSECURED PROMISSORY NOTE (Filed With SEC on September 16, 2010)

REVOLVING CREDIT AGREEMENT Between: THEKOSKI FAMILY LIMITED PARTNERSHIP, a Texas Limited Partnership as Lender and ORAGENICS, Inc., a Florida Corporation as Borrower. Loan Amount:... (Filed With SEC on August 2, 2010)

Exhibit1.21 (Filed With SEC on July 7, 2010)

Exhibit2.2(c) REVOLVINGCREDIT AGREEMENT Between: THEKOSKI FAMILY LIMITED PARTNERSHIP, a TexasLimited Partnership as Lender and ORAGENICS, Inc., a FloridaCorporation as Borrower.... (Filed With SEC on July 7, 2010)

COMMONSTOCK PURCHASE AGREEMENT (Filed With SEC on July 7, 2010)

UNSECUREDPROMISSORY NOTE WITH CONVERSION PROVISIONS (Filed With SEC on May 28, 2010)

COMMONSTOCK PURCHASE AGREEMENT (Filed With SEC on March 31, 2010)

SECONDAMENDMENT TO AMENDEDAND RESTATED ORAGENICS,INC. 2002STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on October 30, 2009)

ARTICLESOF AMENDMENT TO ARTICLESOF INCORPORATION OF ORAGENICS,INC. (DocumentNumber P96000091949) (Filed With SEC on October 30, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 6, 2009)

SECUREDPROMISSORY NOTE (Filed With SEC on July 6, 2009)

SECURITYAGREEMENT (Filed With SEC on July 6, 2009)

EMPLOYMENT AGREEMENT OF DAVID B. HIRSCH EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2008)

EXHIBIT SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 16, 2008)

Securities Purchase Agreement Definitive Term Sheet (Filed With SEC on June 3, 2008)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 7, 2008)

FIRST AMENDMENT TO AMENDED AND RESTATED (Filed With SEC on April 14, 2008)

AMENDMENT NO. 1 TO WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORAGENICS, INC. (Filed With SEC on January 31, 2008)

AMENDMENT NO. 1 TO WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORAGENICS, INC. (Filed With SEC on January 17, 2008)

Category

Industry

Companies

Contracts

ORAGENICS INC Contracts & Agreements